Active Shortage

GLN-ATOVAQUONE

GLENMARK PHARMACEUTICALS CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of GLN-ATOVAQUONE in Canada?

Yes. GLN-ATOVAQUONE 750MG has an active shortage reported to Health Canada (last updated October 16, 2026).

Why is GLN-ATOVAQUONE not available?

The reason the manufacturer reported: Demand increase for the drug.

When will GLN-ATOVAQUONE be available again?

The manufacturer's estimated resolution date is October 21, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Expected resolution~3 days remaining (estimate)

Affected strength750MG

Report last updated2026-10-16

Checked by MedShort2026-10-17

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MEPRON

GLAXOSMITHKLINE INC

750MG · DIN 02217422

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-ATOVAQUONE

AURO PHARMA INC

750MG · DIN 02556618

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-10-21

~3 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02528495

Strength

750MG

Dosage Form

SUSPENSION

Route

ORAL

Active Ingredient

ATOVAQUONE

Tier

Unrated

Last Updated

2026-10-16

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from GLENMARK PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

DIN 02466783

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

DIN 02462060

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21

DIN 02421437

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28

DIN 02421445

GLN-APREMILAST

30MG · DIN 02518910

GLN-BILASTINE

20MG · DIN 02544369